Intellia Therapeutics (NASDAQ:NTLA) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Intellia Therapeutics missed estimated earnings by 78.18%, reporting an EPS of $-1.96 versus an estimate of $-1.1.
Revenue was up $4.81 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 10.18% increase in the share price the next day.
Here's a look at Intellia Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.94 | -0.84 | -0.63 | -0.67 |
| EPS Actual | -1.09 | -0.97 | -1.01 | -0.69 |
| Revenue Estimate | 8.26M | 8.66M | 11.89M | 8.57M |
| Revenue Actual | 12.85M | 7.20M | 6.55M | 6.45M |
To track all earnings releases for Intellia Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
